Corbion Q3 2020 Interim Management Statement
02 November 2020 - 7:00AM
Corbion Q3 2020 Interim Management Statement
Corbion reported sales of € 741.2 million in the first
nine months of 2020, an increase of 1.7% due to organic net sales
growth of 4.4% partly offset by currency effects. Organic net sales
growth in core activities was 5.8%. Adjusted EBITDA in the first
nine months increased organically by 17.3% to € 128.4 million due
to improvements in all business segments.
“After navigating through a volatile first half of the year, the
net impact of the COVID-19-pandemic in the third quarter is
diminishing. The third quarter showed strong organic growth in our
Core activities. I am therefore proud of this strong delivery by
our people, working under continued challenging circumstances.
Sustainable Food Solutions is showing organic growth above market
growth as we continue to gain traction with our natural
preservation solutions. Lactic Acid & Specialties continues to
perform well in all segments with the notable exception of the
medical biopolymers, which is adversely impacted by postponements
of elective surgeries. In Incubator we are cautiously optimistic
about the impact of our revised market approach on our algae-based
omega-3 business. We are in the process of scaling up our newly
installed lactic acid capacity in Thailand after completing the
debottlenecking project in June. Additionally, we are expanding our
debottlenecking investments to facilitate growth in the lactic acid
markets. We recently announced the intention to build a new PLA
plant in France by the Total Corbion PLA joint venture as PLA
continues to develop very positively”, commented Olivier Rigaud,
CEO.
Key financial highlights first nine months of
2020
- Net sales growth YTD was 1.7%; organic growth was 4.4% (5.8%
for core activities)
- Adjusted EBITDA YTD was € 128.4 million, an organic increase of
17.3%
- Adjusted EBITDA margin YTD was 17.3% (17.6% for core
activities)
- Operating result YTD was € 89.4 million, an organic increase of
28.8%
€ million Corbion Total
Company |
YTD 2020 |
YTD 2019 |
Total growth |
Organic growth |
Net sales |
741.2 |
728.9 |
1.7% |
4.4% |
Adjusted EBITDA |
128.4 |
112.1 |
14.5% |
17.3% |
Adjusted EBITDA
margin |
17.3% |
15.4% |
|
|
Operating result |
89.4 |
71.4 |
25.2% |
28.8% |
- 20201102 Corbion PR 3Q20 ENG
Corbion N.V (EU:CRBN)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Corbion N.V (EU:CRBN)
Historical Stock Chart
Von Jan 2024 bis Jan 2025